| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/03/1992 | WO1992014869A1 Crystallizing biological macromolecules in microgravity |
| 09/03/1992 | WO1992014843A1 Aptamer specific for biomolecules and method of making |
| 09/03/1992 | WO1992014837A1 Intestinal trefoil proteins |
| 09/03/1992 | WO1992014834A1 Insulin-like growth factor binding protein |
| 09/03/1992 | WO1992014833A1 Cell-free and whole cell ice nucleators and process for their production |
| 09/03/1992 | WO1992014832A1 Processes for purifying human bcdf |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014822A1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants |
| 09/03/1992 | WO1992014820A1 Human nerve cell adhesion factor l1, production thereof, and gene coding for the same |
| 09/03/1992 | WO1992014815A1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | WO1992014757A1 Endothelial cell-monocyte adhesion molecule |
| 09/03/1992 | WO1992014754A1 Process for the phosphorylation of insulin and product produced thereby |
| 09/03/1992 | WO1992014752A1 Primitive cell colony stimulating factors vectors, antibodies, and methods of use |
| 09/03/1992 | WO1992014751A1 Peptides for treatment |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014748A1 Identification of a novel human receptor tyrosine kinase gene |
| 09/03/1992 | WO1992014489A1 Poliovirus-based vaccines |
| 09/03/1992 | WO1992014486A1 Transmission blocking vaccine against malaria |
| 09/03/1992 | WO1992014485A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 09/03/1992 | WO1992014481A1 Method and compositions for inducing bone growth |
| 09/03/1992 | WO1991011517A3 Virus/herbicide resistance genes process for producing same and their use |
| 09/03/1992 | DE4125251C1 Drug containing a bovine protein homologous to human MCP-1 - for treating inflammation, tumours, thrombosis, and immune reactions, also for diagnosis |
| 09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |
| 09/03/1992 | CA2106099A1 Cultures of permanent lines of human promyelocyte cells and their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | CA2104698A1 Aptamers specific for biomolecules and methods of making |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | CA2104104A1 Intestinal trefoil proteins |
| 09/02/1992 | WO1992015695A1 Process for the c-terminal modification of peptides having a c_terminal penultimate proline residue |
| 09/02/1992 | WO1992015679A1 Improved epitode displaying phage |
| 09/02/1992 | EP0501914A1 Improved yeast vectors |
| 09/02/1992 | EP0501882A2 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501692A2 Fermentation processes for the production of peptides by a host |
| 09/02/1992 | EP0501650A2 Bacillus thuringiensis genes encoding novel coleopteranactive protein toxins |
| 09/02/1992 | EP0501557A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501280A2 Renin-inhibiting peptide analogues |
| 09/02/1992 | EP0500989A1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 09/02/1992 | EP0500921A1 Na-k-atpase inhibiting natriuretic substances |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500799A1 Particle mediated transformation of animal skin tissue cells |
| 09/02/1992 | EP0500791A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500773A1 Non-glycosylated fgf-4 and compositions containing the same |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500695A1 GnRH ANALOGS |
| 09/02/1992 | EP0500652A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
| 09/02/1992 | EP0500626A1 Promoter, expression vector and polypeptide synthesis |
| 09/02/1992 | EP0500589A1 Purified protein and bioactive pharmaceutical. |
| 09/02/1992 | EP0246279B1 Method for isolation of recombinant polypeptides in biologically active forms |
| 09/02/1992 | CA2105303A1 Display phage |
| 09/02/1992 | CA2101074A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
| 09/02/1992 | CA2062097A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 09/02/1992 | CA2062065A1 Peptide analogues |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/01/1992 | US5144007 Thyroid hormone receptor |
| 09/01/1992 | US5143905 Method and means for extending the host range of insecticidal proteins |
| 09/01/1992 | US5143902 Glucagon analogs with ASP9 replacements or deletions |
| 09/01/1992 | US5143901 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 09/01/1992 | US5143854 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| 09/01/1992 | US5143846 Protease deficient bacterial hosts |
| 09/01/1992 | US5143844 Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| 09/01/1992 | US5143836 Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof |
| 09/01/1992 | US5143830 Process for the production of a polypeptide |
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
| 09/01/1992 | US5143726 T cell epitopes of the hepatitis B virus nucleocapsid protein |
| 09/01/1992 | US5143712 Endothelial leukocyte adhesion molecule-1 blocking agent, antiinflammatory agent |
| 09/01/1992 | CA1307075C PROCESS FOR OBTAINING CONCENTRATES HAVING A HIGH .alpha.-LACTALBUMIN CONTENT FROM WHEY |
| 09/01/1992 | CA1306962C Rhizobium diagnostic sequences |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/28/1992 | WO1992015682A1 Serine-rich peptide linkers |
| 08/28/1992 | WO1992015608A1 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS |
| 08/28/1992 | CA2081471A1 N-(ó-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 08/28/1992 | CA2061918A1 Pharmaceutical compositions comprising a lymphokine |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |
| 08/27/1992 | CA2061797A1 Fermentation processes |
| 08/27/1992 | CA2061721A1 Vector containing an inducible selection gene system |
| 08/26/1992 | EP0500311A2 Biologically active bacillus thuringiensis isolates and gene encoding a cleopteran-active toxin |
| 08/26/1992 | EP0500236A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 08/26/1992 | EP0500108A2 Improved activation of recombinant proteins |
| 08/26/1992 | EP0499993A2 Method for producing human nerve growth factor-2 |
| 08/26/1992 | EP0499990A2 Method for producing cysteine-free peptides |
| 08/26/1992 | EP0499834A2 A blood-stage antigen from Plasmodium falciparum, its preparation and use |
| 08/26/1992 | EP0499681A1 PCTD plasmid isolated form chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccins and/or gianostics |
| 08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use |
| 08/26/1992 | EP0483219A4 Enhancement of musculature in animals |
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 08/26/1992 | EP0460021A4 Chimeric toxin |
| 08/26/1992 | CA2061633A1 Yeast vectors |
| 08/26/1992 | CA2059897A1 Bacillus thuringiensis genes encoding novel coleopteran-active protein toxins |
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule |
| 08/25/1992 | US5142047 Uncharged polynucleotide-binding polymers |
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna |
| 08/25/1992 | US5142026 Recombinant human lymphotoxins that possess N-terminal extended linker peptides for antibody-binding sites |
| 08/25/1992 | US5142025 Diagnosis, therapy aids |
| 08/25/1992 | US5141924 Synthetic vasoactive intestinal peptide analogs |